Immunocompetent C57BL/6 syngeneic mouse ovarian cancer models with defined genetic alterations

Nature·Oct 7

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

researchers have developed immunocompetent c57bl/6 syngeneic mouse ovarian cancer models. these models have defined genetic alterations. the development of these models may be useful for studying ovarian cancer.

Full coverage

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer | Communications Biology

Nature·Nov 13

EPI-SauriCas9-based mouse ovarian cancer models recapitulating pten deletion in patients

Nature·Dec 29

Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade

Nature·Apr 2

Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types

Nature·Aug 6

Tractable mouse TNBC models capture the heterogeneous tumor immune microenvironment and adaptation to PD-L1 blockade

Nature·Dec 26

OBSERVE: guidelines for the refinement of rodent cancer models

Nature·Jul 11

PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancer

Nature·Jun 27

Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

Nature·Mar 21

View original report at Nature ↗

Fetching the latest headlines…